Acitretin
- Level
- Commodity
- Parent
- 51191900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51191913This classification denotes a retinoic acid agent with the molecular formula C21H26O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LCH760E9T7, chemically known as 2,4,6,8-nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (all-e)- but generally known as acitretin, which bears US NIH Compound Identifier 5284513. European Medicines Agency schedules Acitretin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05240MIG. The term ACITRETIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). World Health Organization schedules acitretin in its Anatomical Therapeutic Chemical (ATC) Classification. ACITRETIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule acitretin under HS 29189900 and SITC 51396. As of Q4 2014, ACITRETIN remains the US FDA Preferred Term for this commodity. Acitretin bears US NLM identifiers UMLS ID C0678135 and NCI Concept Code C985. SMILES: O(C1C(C(C(C(C1)C)/C=C/C(=C/C=C/C(=C/C(=O)O)C)C)C)C)C.
Same parent
Under 51191900 · 41Activities that produce or sell this
KBLI · 9Inherited from family 51190000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.